6-oxa-1-azaspiro[3.3]heptan-1-yl-[2-[2-[3-(pentafluoro-λ6-sulfanyl)phenyl]ethyl]pyrimidin-5-yl]methanone
C18H18F5N3O2S — CID 163440005
Data last refreshed: (MolForge compound catalog, from PubChem)
About 6-oxa-1-azaspiro[3.3]heptan-1-yl-[2-[2-[3-(pentafluoro-λ6-sulfanyl)phenyl]ethyl]pyrimidin-5-yl]methanone
6-oxa-1-azaspiro[3.3]heptan-1-yl-[2-[2-[3-(pentafluoro-λ6-sulfanyl)phenyl]ethyl]pyrimidin-5-yl]methanone (PubChem CID 163440005) has the molecular formula C18H18F5N3O2S and a molecular weight of 435.42 g/mol. Its IUPAC name is 6-oxa-1-azaspiro[3.3]heptan-1-yl-[2-[2-[3-(pentafluoro-λ6-sulfanyl)phenyl]ethyl]pyrimidin-5-yl]methanone.
Molecular Properties
| Compound Name | 6-oxa-1-azaspiro[3.3]heptan-1-yl-[2-[2-[3-(pentafluoro-λ6-sulfanyl)phenyl]ethyl]pyrimidin-5-yl]methanone |
|---|---|
| PubChem CID | 163440005 |
| Molecular Formula | C18H18F5N3O2S |
| Molecular Weight | 435.42 g/mol |
| Exact Mass | 435.10 |
| IUPAC Name | 6-oxa-1-azaspiro[3.3]heptan-1-yl-[2-[2-[3-(pentafluoro-λ6-sulfanyl)phenyl]ethyl]pyrimidin-5-yl]methanone |
| SMILES | O=C(c1cnc(CCc2cccc(S(F)(F)(F)(F)F)c2)nc1)N1CCC12COC2 |
| InChI | InChI=1S/C18H18F5N3O2S/c19-29(20,21,22,23)15-3-1-2-13(8-15)4-5-16-24-9-14(10-25-16)17(27)26-7-6-18(26)11-28-12-18/h1-3,8-10H,4-7,11-12H2 |
| InChIKey | AXRYRWSIUAYFEA-UHFFFAOYSA-N |
| XLogP | 4.53 |
| TPSA | 55.32 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 29 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 435.42 |
| LogP ≤ 5 | 4.53 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 4 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 163440005 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.